The first strains of Vibrio cholerae with transferable multiple resistance were isolated during 1964 and 1965 in the Philippines (6, 7) . It seems, however, that the resistance factors acquired by these strains were maintained with difficulty and were not easily transferable to enterobacteria. In contrast, a strain of V. cholerae isolated in Algeria in 1971 had a very stable R plasmid which was easily transferable to Escherichia coli K-12 (15) . All V. cholerae plasmids later isolated in Algeria belonged to the 6-C incompatibility group (14) .
On 27 August 1981, we isolated V. cholerae from stool samples of four Algerians returning from a stay in Algeria. The four strains were susceptible to most antibiotics and quickly disappeared from the stools of three of these patients after treatment with trimethoprim (8 mg/kg per day) and sulfamethoxazole (40 mg/kg per day). In contrast, in the fourth patient treated with the same antibiotics, the bacterium persisted for eight days and became resistant to ampicillin, chloramphenicol, sulfonamide and trimethoprim (Apr, Cmr, Sur, and Tpr). Resistance was transferable by conjugation to E. coli with a low frequency (7 x 10-6). Conjugation was performed in a brain heart agar broth, with the resistant V. cholerae strain (2 x 108 bacteria per ml) being mixed with recipient strains (E. coli K-12 UB1139 leu met thy nal or JC3272 trp his lys str [8 X 108 bacteria per ml]) for 3 h at 37°C. The transconjugants UB1139 (Apr, Cmr, Sur, and Tpr) and JC3272 (Apr, Cmr, Sur, and Tpr) were isolated on appropriate selective media. It was also possible to obtain transfer-of-resistance markers of UB1139 (Apr, Cmr, Sur, and Tpr) to JC3272 by conjugation.
Isolation of the resistance plasmid, which we named pYMB2, was performed as described by Kado et This activity was also found in the transconjugants E. coli UB1139(pYMB2) and JC3272(pYMB2). The substrate profile of beta-lactamase coded by pYMB2 was determined * Corresponding author.
(microacidimetric method at pH 7.0 and 37°C) (8) by using bacterial extracts prepared as previously reported (10) . The maximal rates of hydrolysis were achieved with a saturated concentration of 0.24 mM for penicillins and 6.5 mM for cephalosporins. Results were suggestive of a TEM-type beta-lactamase. The nature of the enzyme was confirmed by analytical isoelectric focusing (5% polyacrylamide gel; pH gradient of 4 to 6.5; 400 V; 18 h at 10°C), with enzymatic activity being detected with nitrocefin (12). The V. cholerae beta-lactamase focused at pH 5.4, at the same point as the TEM-1 enzyme coded by plasmid R6K, and the TEM-2 enzyme coded by RP4 focused at pH 5.6 (Fig. 1) acetyltransferase (13) . Trimethroprim resistance is presently under investigation (J. Burchall, unpublished data) to determine which of the various resistant dihydrofolate reductases is involved (16) .
The V. cholerae plasmid was incompatible with group 6-C plasmids. This was shown by transferring reference plasmids of group 6-C, R55 (Apr, Cmr, Gmr, Kmr, and Sur) or R16a (Apr, Kmr, and Sur) from K-12 strains to JC3272(pYMB2). Transconjugants no longer had the markers of pYMB2, only those of the reference plasmid. Similarly, when pYMB2 was transferred to strains carrying R55 or R16a, the resideht plasmids were eliminated, and pYMB2 was stably established.
The persistence of V. cholerae in the stool samples from patients during trimethoprim-sulfamethoxazole treatment was presumably due to the acquisition by the bacterium of resistance plasmid pYMB2 which, like other plasmids isolated in V. cholerae in the last decade, belonged to incompatibility group 6-C (4, 15) . A study of the antibiotic resistance of the intestinal flora associated with the Vibrio strain might have allowed us to determine the origin of the plasmid. But because we were preoccupied by the clinical situation, the study was not performed. However, the beta-lactamase coded by this plasmid was of the TEM-1 type, as are the large majority of beta-lactamases coded by plasmids of enterobacteria (2) .
The ability of V. cholerae to acquire an R plasmid during treatment and the subsequent dissemination of these strains selected by antibiotherapy constitute an epidemiological danger, especially since sulfonamide chemoprophylaxis is used against cholera.
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